MedTrace Logo

Efficacy and Safety Study of Complete Mesocolic Excision for Colon Cancer

NCT01724775 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2016-08-18

No results posted yet for this study

Summary

In 2009, Prof. Hohenberger proposed complete mesocolic excision (CME) as standardized, in which the same principle of TME in rectal cancer has been applied to the colon. More and more surgeons pay attention to the rationality of this surgical approach. However, the clinical application researches are still few, in particular the prospective controlled study is still none. This clinical trial will compare the CME group and non-CME group to evaluate the outcome and safety of CME for apply in clinic.

Conditions

Sponsors & Collaborators

  • Shan Wang

    lead OTHER

Principal Investigators

  • Yingjiang Ye, M.D. & Ph.D. · Peking University People's Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2017-11-30
Completion
2017-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01724775 on ClinicalTrials.gov